Navigation Links
Naturopathix, Inc. Brings Painless Molluscum Treatment to Asia on Governor's Trade Mission
Date:3/29/2013

Boise, ID (PRWEB) March 29, 2013

“We are delighted to have this opportunity to bring our painless molluscum treatment to people in Asia. ZymaDerm™ provides a simple and effective all natural dab on preparation which allows parents to avoid expensive, painful, and other usually ineffective treatments,” continued Dr. Burke.

"Idaho Governor "Butch" Otter has invited Naturopathix,Inc., along with several other select companies with innovative products, to travel to Asia this April on the Governor's Trade Mission", announced Briant Burke, MD, MS creator of ZymaDerm™ and medical director of Naturopathix,Inc.

ZymaDerm™ is the most widely used painless and inexpensive natural treatment to rapidly make the unsightly skin bumps simply vanish, especially in children. Since its introduction in 2003, it has enabled hundreds of thousands of people to quickly be rid of visible bumps caused by MCV.

The unsightly skin condition is highly contagious and is caused by the molluscum contagiosum virus. MCV is a pox virus but it is not related to chicken pox. The lesions often rapidly spread and occur most often on the face, neck, armpit, arms, and hands. However, it may occur anywhere on the body except the palms of the hands and soles of the feet.

Contagiosum in children is more common than in adults. They catch it when they come into contact with the virus, usually on the skin of another infected child or on a wet surface infected with the virus. It is a common infection throughout the world with an increased incidence in hot tropical and semi-tropical climates. In the US there are approximately 2 million new cases each year. However in Taiwan with its humid tropical climate there are an estimated 3 million cases, even though the population is much smaller. "We feel we can serve a real need by helping to bring relief to the peoples of Asia inflicted with this embarrassing condition", said Dr. Burke. Symptoms of this skin virus include raised, unsightly, warty lesions or bumps on the skin.

While the skin virus occurs primarily in young children, it is becoming epidemic amongst adults as well. ZymaDerm™ is as effective for adults as well as children, and may be used safely on all body areas including the face and private areas.

Many leading dermatology clinics and pediatricians are now replacing invasive and often painful treatments with this gentle, effective, natural treatment for their patients with molluscum contagiosum. Results of an independent follow up study of 356 physicians who used ZymaDerm™ samples found 86% reported ZymaDerm™ to be effective or highly effective in eliminating visible molluscum lesions in children.

A patented blend of powerful all natural plant-based compounds, ZymaDerm™ transforms the treatment of molluscum contagiosum from expensive and often painful procedures such as freezing, burning, or surgical removal of the lesions to simply dabbing on a pleasant aromatic blend twice a day, usually for less than a month, until the lesions completely vanish.

ABOUT ZYMADERM™

Naturopathix,Inc. was founded in 2002 with the mission to develop novel plant based therapeutic treatments for the relief of common medical conditions. The company is led by Dr. Briant Burke, a practicing physician and distinguished medical research scientist with over 20 years of clinical experience treating patients and publishing clinical trials. ZymaDerm™ for molluscum contagiosum is FDA approved as a homeopathic drug. Its ingredients are officially included in the Homeopathic Pharmacopeia of the United States as useful agents. The potency and level of purity of the ingredients in ZymaDerm™ meet the most stringent standards of excellence.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10564773.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Finding brings scientists 1 step closer to Parkinsons drug
2. Breakthrough Brings Transparency to Male/Female Relationships
3. Conference brings global focus to social inequality
4. Telephone therapy technique brings more Iraq and Afghanistan veterans into mental health treatment
5. Winter Brings Rise in Heart-Related Deaths, Study Finds
6. Lice Tamers Brings FDA-Cleared LouseBuster™ Device to Suffolk County
7. Acoustical Treatment Brings Tidings of Comfort and Joy on ASI Blogs
8. Catalyst Exhibits Brings Big Presence to 2012 RSNA Show
9. Maui Wowi Brings Hawaii to the Atlantic
10. Fidelity Investments Brings the Happiness of the Holidays to Five Educational First Steps Assisted Centers
11. LesserEvil Healthy Brands Brings Chia Crisps to Wegman's
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , ... January 19, 2017 , ... St. Catherine’s Village ... , Siena Center is a skilled nursing facility on the grounds of the St. ... rooms. It recently was voted the best nursing home in Mississippi for the second ...
(Date:1/19/2017)... ... ... The CHP suggests that California drivers can avoid hydroplaning as well as ... the space between themselves and other vehicles, according to a January 3 article ... notes that, rain or shine, drivers should always incorporate safe driving practices in their ...
(Date:1/19/2017)... Marriottsville, MD (PRWEB) , ... January 19, 2017 , ... ... launched six new clients into the US market. , Over the past 20 years ... the past 4 weeks SFI has launched six new clients into the US market. ...
(Date:1/19/2017)... ... 19, 2017 , ... Dr. Maz Ghodsian ... the opening of 3 medical offices specializing specifically in hemorrhoid treatment and ... Angeles (Beverly Hills), Hemorrhoids Center of Newport Beach, and Hemorrhoids Center of ...
(Date:1/18/2017)... , ... January 18, 2017 , ... From a health ... released almost daily linking gut health to chronic disease, mental health and general physical ... ” as an important resolution to consider. , For one Charlottesville restaurant, good gut ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... consumables for the medical and veterinary markets worldwide, has ... for the third quarter fiscal year 2017, ended December ... ET on Thursday, January 26, 2017.  The Company will ... 2017 after the market closes on Thursday, January 26, ...
(Date:1/19/2017)... Massachusetts , January 19, 2017 ... ) announced that the U.S. Food and Drug Administration ... of a New Drug Application (NDA) for SHP465, a ... evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder ... on or around June 20, 2017, the designated Prescription ...
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
Breaking Medicine Technology: